Mumps Vaccine (MumpsVax) Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Mumps Vaccine (MumpsVax) Market?
The escalating occurrence of infectious diseases is anticipated to boost the expansion of the mumps vaccine (mumpsvax) market. Illnesses prompted by infectious agents like viruses, bacteria, fungi, or parasites that can be transferred from human to human or via polluted environments define infectious diseases. The surge in infectious diseases can be attributed to factors like urbanization, climate alteration, globalization and changes in human demographics and behaviors, escalating the emergence and transmission of pathogens. Mumpsvax, a vaccine used primarily to avert mumps infection, exists as an infectious disease triggered by the mumps virus and is frequently included in the MMR (measles, mumps, rubella) vaccination. For example, a UK Health Security Agency report in August 2024 indicated that the West Midlands region had reported the most measles cases in 2023, with 160 cases (44%), followed by London with 122 cases (33%). Interestingly, children below ten years old accounted for 63% of the total cases, equating to 232 cases. The end of the year saw an upsurge in measles activity, with 157 new instances recorded in December as opposed to just 45 in November. Thus, the elevated prevalence of infectious diseases is fuelling the mumps vaccine (mumpsvax) market. Acceleration in healthcare expenditure is projected to boost the mumps vaccine (mumpsvax) market by enhancing mumpsvax access and immunization rates. The term healthcare expenditure encompasses the aggregate sum spent on health care goods and services, inclusive of personal healthcare, preventive actions, and public health activities, with the end goal of ameliorating health outcomes within a specific timespan. The increment in healthcare expenditure can be ascribed to factors like an aging populace, chronic diseases, advanced medical tech, high drug cost, inefficient payment systems, and augmented demand for services. The rise in healthcare expenditure impacts the mumps vaccine (mumpsvax) by elevating funding for vaccination initiatives, thereby improving vaccine accessibility and promoting better public health outcomes via escalated immunization rates against mumps. A report by the Office For National Statistics in May 2024 emphasized that between 2022 to 2023, total healthcare expenditure rose by 5.6% in nominal terms, compared to a growth rate of 0.9% in 2022. Total healthcare and social care expenditure for the long term also rose by 2.8% in real terms in 2022. Thus, increasing healthcare expenditure is fuelling the mumps vaccine (mumpsvax) market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19909&type=smp
#What Growth Opportunities Will Drive the Mumps Vaccine (MumpsVax) Market’s CAGR Through 2034?
The mumps vaccine (mumpsvax) market has expanded steadily. It is expected to increase from $2,057.93 million in 2024 to $2,210.59 million in 2025 at a 7.4% CAGR. Drivers include rising childhood immunization rates, global health campaigns, growing trust in vaccines, travel awareness, and more immunization programs.
The Mumps Vaccine (Mumpsvax) market is forecasted to expand, growing to $2,902.21 million by 2029 with a CAGR of 7.0%. Growth factors include the resurgence of vaccine-preventable diseases, improved public awareness of adult immunization, increasing health consciousness, government-backed immunization drives, and strengthened global health initiatives. Emerging trends involve tailored vaccination plans, integration of digital health tools, improved disease surveillance, intensified R&D in adult vaccines, and the application of AI in vaccine strategy.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19909
Who Are the Top Companies Driving Innovation and Growth in theMumps Vaccine (MumpsVax) Market?
Major companies operating in the mumps vaccine (mumpsvax) market include Merck & Co. Inc., GlaxoSmithKline plc
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/mumps-vaccine-mumpsvax-global-market-report
Which Key Market Segments Comprise the Mumps Vaccine (MumpsVax) Market and Drive Its Revenue Growth?
The mumps vaccine (mumpsvax)market covered in this report is segmented –
1) By Product Type: Monovalent; Combinational; Divalent; Trivalent; Other Product Types
2) By Age Group: Pediatric; Adult
3) By Distribution Channels: Hospital pharmacies; Drug Stores; Retail Pharmacies
4) By End-User: Pediatric Clinic; Hospitals; Non-Governmental Organization (NGOs); Other End-Users
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=19909&type=smp
Which Regions Are Emerging as Leaders in the Mumps Vaccine (MumpsVax) Market?
North America was the largest region in the mumps vaccine (mumpsvax) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mumps vaccine (mumpsvax) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Mumps Vaccine (MumpsVax) Market 2025, By The Business Research Company:
Dendritic Cell Cancer Vaccine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dendritic-cell-cancer-vaccine-global-market-report
Porcine Epidemic Diarrhea Vaccines Global Market Report 2025
Global Biosimilar Hormones Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
